First light biosciences, inc. product pipeline analysis
Bio marker strategies, llc product pipeline analysis
1. BioMarker Strategies, LLC - Product Pipeline Analysis
Market Research Reports Distributor - Aarkstore.com have vast database on market research reports, company
financials, company profiles, SWOT analysis, company report, company statistics, strategy review, industry
report, industry research to provide excellent and innovative service to our report buyers.
Aarkstore.com have very interactive search feature to browse across more than 2,50,000 business industry
reports. We are built on the premise that reading is valuable, capable of stirring emotions and firing the
imagination. Whether you're looking for new market research report product trends or competitive industry
analysis of a new or existing market, Aarkstore.com has the best resource offerings and the expertise to make
sure you get the right product every time.
2. BioMarker Strategies, LLC - Product Pipeline Analysis
Summary
BioMarker Strategies, LLC (BioMarker Strategies) is a tissue-based cancer diagnostics company. The companys
product SnapPath, a novel automated tumor biopsy processing and testing system, is used to quickly test and
analyze a patient’s live solid tumor sample at the point of biopsy. In addition to generating traditional DNA-based
molecular profiles, it also generates phenotypic profiles of cancer patients. The company is headquartered at
Baltimore in Maryland, the US.
This report is a source for data, analysis and actionable intelligence on the BioMarker Strategies, LLC portfolio of
pipeline products. The report provides detailed analysis on each pipeline product with information on the
indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date,
and estimated launch date
Each pipeline product is profiled to cover information on product description, function, technology, indication,
and application. The report is also supplemented with a detailed company profile and information on clinical
trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary
research and in-house analysis by GlobalData’s team of industry experts.
3. Scope
- Detailed company profile with information on business description, key company facts, major products and
services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and
by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and
estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology,
indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status,
trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym,
participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study
type, trial site, trial funding, age eligibility, and gender eligibility.
4. Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices
pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust
return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to
gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline
products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-
value products that your competitor would add in its portfolio? – identify, understand and capitalize.
5. List of Tables 3
List of Figures 4
Key Facts 5
BioMarker Strategies, LLC - Major Products and Services 6
BioMarker Strategies, LLC Pipeline Products by Equipment Type 7
BioMarker Strategies, LLC Pipeline Products by Development Stage 9
BioMarker Strategies, LLC Pipeline Products by Therapy Area 11
BioMarker Strategies, LLC Pipeline Products by Milestone Summary 13
ABA-PROSTATE 14
ABA-PROSTATE Product Status 14
ABA-PROSTATE Product Description 14
Ex Vivo Biomarker Test - Breast Cancer 15
Ex Vivo Biomarker Test - Breast Cancer Product Status 15
Ex Vivo Biomarker Test - Breast Cancer Product Description 15
Ex Vivo Biomarker Test - Breast Cancer Product Patent Details 15
Ex Vivo Biomarker Test - Colon Cancer 19
Ex Vivo Biomarker Test - Colon Cancer Product Status 19
Ex Vivo Biomarker Test - Colon Cancer Product Description 19
Ex Vivo Biomarker Test - Lung Cancer 20
Ex Vivo Biomarker Test - Lung Cancer Product Status 20
Ex Vivo Biomarker Test - Lung Cancer Product Description 20
Ex Vivo Biomarker Test - Melanoma 21
Ex Vivo Biomarker Test - Melanoma Product Status 21
Ex Vivo Biomarker Test - Melanoma Product Description 21
Ex Vivo Biomarker Test - Pancreatic Cancer 22
Ex Vivo Biomarker Test - Pancreatic Cancer Product Status 22
Ex Vivo Biomarker Test - Pancreatic Cancer Product Description 22
Ex Vivo Biomarker Test - Solid Tumors 23
Ex Vivo Biomarker Test - Solid Tumors Product Status 23
Ex Vivo Biomarker Test - Solid Tumors Product Description 23
SnapPath Biomarker Testing System 24
SnapPath Biomarker Testing System Product Status 24
SnapPath Biomarker Testing System Product Description 24
SnapPath Biomarker Testing System Product Milestone 24
BioMarker Strategies, LLC - Key Competitors 26
BioMarker Strategies, LLC - Key Employees 27
BioMarker Strategies, LLC - Locations And Subsidiaries 28
6. Head Office 28
Recent Developments 29
BioMarker Strategies, LLC, Recent Developments 29
Oct 03, 2012: BioMarker Strategies Appoints Jack Davis As Executive Chairman 29
May 27, 2011: BioMarker Strategies Appoints Glenn Miller To Board Of Directors As Chairman 29
Jan 03, 2011: BioMarker Strategies Appoints Three New Directors 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30
List of Figures
BioMarker Strategies, LLC Key Pipeline Products by Equipment Type 1
BioMarker Strategies, LLC Pipeline Products by Equipment Type 7
BioMarker Strategies, LLC Pipeline Products by Development Stage 9
BioMarker Strategies, LLC Pipeline Products by Therapy Area 11
BioMarker Strategies, LLC Pipeline Products by Milestone Summary 13
7. List of Tables
BioMarker Strategies, LLC, Key Facts 1
BioMarker Strategies, LLC Key Pipeline Products by Equipment Type 1
BioMarker Strategies, LLC Key Pipeline Products by Therapy Area 1
BioMarker Strategies, LLC Key Pipeline Products by Development Stage 1
BioMarker Strategies, LLC, Key Facts 5
BioMarker Strategies, LLC, Major Products and Services 6
BioMarker Strategies, LLC Number of Pipeline Products by Equipment Type 7
BioMarker Strategies, LLC Pipeline Products by Equipment Type 8
BioMarker Strategies, LLC Number of Pipeline Products by Development Stage 9
BioMarker Strategies, LLC Pipeline Products by Development Stage 10
BioMarker Strategies, LLC Number of Pipeline Products by Therapy Area 11
BioMarker Strategies, LLC Pipeline Products by Therapy Area 12
BioMarker Strategies, LLC Number of Pipeline Products By Milestone Summary 13
BioMarker Strategies, LLC Pipeline Products by Milestone Summary 13
ABA-PROSTATE - Product Status 14
ABA-PROSTATE - Product Description 14
Ex Vivo Biomarker Test - Breast Cancer - Product Status 15
Ex Vivo Biomarker Test - Breast Cancer - Product Description 15
Ex Vivo Biomarker Test - Breast Cancer - Patent Details1 15
Ex Vivo Biomarker Test - Breast Cancer - Patent Details2 16
Ex Vivo Biomarker Test - Breast Cancer - Patent Details3 16
Ex Vivo Biomarker Test - Breast Cancer - Patent Details4 17
Ex Vivo Biomarker Test - Breast Cancer - Patent Details5 17
Ex Vivo Biomarker Test - Breast Cancer - Patent Details6 18
Ex Vivo Biomarker Test - Colon Cancer - Product Status 19
Ex Vivo Biomarker Test - Colon Cancer - Product Description 19
Ex Vivo Biomarker Test - Lung Cancer - Product Status 20
Ex Vivo Biomarker Test - Lung Cancer - Product Description 20
Ex Vivo Biomarker Test - Melanoma - Product Status 21
Ex Vivo Biomarker Test - Melanoma - Product Description 21
Ex Vivo Biomarker Test - Pancreatic Cancer - Product Status 22
Ex Vivo Biomarker Test - Pancreatic Cancer - Product Description 22
Ex Vivo Biomarker Test - Solid Tumors - Product Status 23
Ex Vivo Biomarker Test - Solid Tumors - Product Description 23
SnapPath Biomarker Testing System - Product Status 24
SnapPath Biomarker Testing System - Product Description 24
SnapPath Biomarker Testing System - Product Milestone 24
BioMarker Strategies, LLC, Key Employees 27
8. Related Reports
For more information, please visit:
http://www.aarkstore.com/reports/BioMarker-Strategies-LLC-Product-Pipeline-Analysis-240207.html
Or email us at contact@aarkstore.com or call +919272852585
More Reports
http://www.aarkstore.com/publishers/GlobalData-61.html
Related Reports
• Competitive Intelligence: Leading Coagulation Market Players--Strategic Assessments of Major Suppliers and Emerging Mark
• HeartSine Technologies, Inc. - Strategic SWOT Analysis Review
• The Cooper Companies, Inc. (COO) - Financial and Strategic SWOT Analysis Review
• Goold Health Systems, Inc. - Strategic SWOT Analysis Review
• Atrium Medical Corporation - Strategic SWOT Analysis Review
• iRhythm Technologies, Inc. - Strategic SWOT Analysis Review
• Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review
• Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review
• Adpo Group NV - Strategic SWOT Analysis Review
• Becton, Dickinson and Company (BDX) - Financial and Strategic SWOT Analysis Review
9. Contact Us
Aarkstore E nterprise
T : +912227453309
el
M obile No:+08149852585
Email : contact@aarkstore.com
W ebsite : http:/www.aarkstore.com
/
Blog: http:/www.emarketreports.com
/
http:/teju-aarkstoreenterprise.blogspot.in
/
Follow us on twitter: http:/twitter.com/
/ aarkstoredotcom
http:/in.linkedin.com/ aarkstore
/ in/
http:/www.facebook.com/
/ aarkstoreenterprise
10. Contact Us
Aarkstore E nterprise
T : +912227453309
el
M obile No:+08149852585
Email : contact@aarkstore.com
W ebsite : http:/www.aarkstore.com
/
Blog: http:/www.emarketreports.com
/
http:/teju-aarkstoreenterprise.blogspot.in
/
Follow us on twitter: http:/twitter.com/
/ aarkstoredotcom
http:/in.linkedin.com/ aarkstore
/ in/
http:/www.facebook.com/
/ aarkstoreenterprise